S&P 500 7412.84 +0.19%
NASDAQ 26274.12 +0.10%
TASI 11166.83 +0.08%
Oil (WTI) 101.05 +3.04%
Oil (Brent) 106.82 +2.50%
VIX 18.85 +2.56%
Gold 4709.30 -0.41%
USD/SAR 3.75 +0.01%

Beam Therapeutics Inc.

BEAM · Healthcare · · USD
31.75 USD
0.00 (-1.76%)
● Updated 2026-05-12 11:52 Saudi Time ↻ Refresh
Short-term Mid-term Long-term

Fahodi Score BUY Mid-term (Position)

80
/ 100
Technical 100
Trend & RS 98
Momentum 80
Fundamental 33
Macro 65
Liquidity 40
ComponentScoreWeight
Technical 100.0 20%
Trend & RS 98.0 30%
Momentum 80.0 15%
Fundamental 33.3 10%
Macro 65.1 20%
Liquidity 40.2 5%

Trade Setup

Entry 31.75
Stop Loss 27.57 (13.2%)
Target 1 (1:1) 35.93 (+13.2%)
Target 2 (2:1) 40.11 (+26.3%)
ATR(14) 2.09 (6.6%)
Risk per Share 4.18
Reward:Risk 2:1

ATR-based levels. Adjust for support/resistance zones.

Factor Profile

Factor Score Z Bar
Value 76.7 +1.07
Momentum 80.0 +1.20
Quality 36.2 -0.55
Composite 64.3

Quality Scores

Piotroski F-Score 3 /9 — Weak
1. Positive Net Income 2. Positive Roa 3. Positive Cfo 4. Quality Earnings 5. Lower Leverage 6. Higher Liquidity 7. No Dilution 8. Higher Gross Margin 9. Higher Asset Turnover
Altman Z-Score Insufficient Data

Valuation vs Peers Undervalued

MetricStockSectorvs Peers
P/E Ratio N/A 22.0 Inline
P/B Ratio 2.7 4.0 Below

Comparing against Healthcare median multiples.

Trading at a discount to sector peers — potential value opportunity.

Position Sizing — Kelly Criterion

4.5%
Recommended Size
51.4%
Full Kelly
25.7%
Half Kelly
5.0%
Max Cap (Moderate)

Kelly inputs derived from quant score 80/100. Estimated win rate 64%, avg win 9.8%, avg loss 3.4%. Position was capped at the moderate risk maximum. This is analytical output, not a recommendation to trade.

BEAR Regime: BEAR (20% confidence) — position size reduced 10%

Signal Summary STRONG BUY

4
Bullish Signals
0
Bearish Signals
57.68
RSI(14)
1.1482
MACD

Relative Strength (RS) IMPROVING

94
/ 99
RS Rating
O'Neil PASS (≥80)
RS vs SPY ↑ RISING (+9.6% vs SPY 3M)
RS vs Sector OUTPERFORMING (Healthcare)
RS New High No (53d since high)
Sector Outperformance +18.9% (3M)
RS Line — stock / SPY (90 bars)
← older newer →
RS vs SPY 50-day SMA of RS
IMPROVING: Gaining momentum — the stock is starting to outperform the market. Watch for RS new high confirmation.

Technical Indicators

IndicatorValueSignal
Rsi 57.68 NEUTRAL
Macd 1.1482 BULLISH
Ma Cross 27.47 / 25.33 GOLDEN CROSS
Trend Short ABOVE SMA50
Trend Long ABOVE SMA200
Bollinger MIDDLE
Volume 1.11x NORMAL

Key Levels

LevelPrice
52-Week High36.44
Bollinger Upper33.02
SMA(200)25.33
SMA(50)27.47
SMA(20)30.53
Current Price31.75
Bollinger Lower28.04
52-Week Low15.35
ATR(14)2.09

Advanced Technical Analysis

Click to expand

Wyckoff Phase & Volume Spread Analysis

Wyckoff Phase

ACCUMULATION A Confidence
50%
Selling Climax
Acc: 2.0  |  Dist: 0.0  |  Markup: 2.0  |  Markdown: 0.0

Volume Spread Analysis (last 5 bars)

DateSignalVolDescription
2026-05-05 Normal 0.94x Normal bar — no special VSA pattern
2026-05-06 Normal 1.01x Normal bar — no special VSA pattern
2026-05-07 Normal 0.81x Normal bar — no special VSA pattern
2026-05-08 Normal 1.31x Normal bar — no special VSA pattern
2026-05-11 Normal 1.11x Normal bar — no special VSA pattern

Ichimoku Cloud BULLISH

LineValueStatus
Tenkan-sen (9) 31.44 Above Kijun
Kijun-sen (26) 28.91 Base line
Senkou A 30.17 Leading span A
Senkou B 28.00 Leading span B
Cloud 28.00 – 30.17 Bullish (Green)
Price vs Cloud 31.75 Above Cloud
Chikou Span 24.23 Bullish
Alignment Score 4/4 BULLISH

TTM Squeeze & Divergences

TTM Squeeze

SQUEEZE ON 4 bars Momentum: BULLISH FADING
BB: 28.04 – 33.02  |  KC: 27.39 – 33.66

Divergences (last 60 bars)

TypeIndicatorBars AgoStrength
Regular Bearish RSI 4

Anchored VWAP

VWAP: 24.11 Anchor: 2025-05-30 (52w Low) ABOVE AVWAP +31.7%

Heikin-Ashi Trend

BULLISH Full data via /api/advanced/BEAM

Valuation

MetricValue
Market Cap3.27B
P/E (TTM)N/A
Forward P/EN/A
P/B2.71
EPS-0.49

Financial Health

MetricValue
Revenue Growth3.2%
Profit Margin-40.2%
ROE-5.8%
Debt/Equity21.54
Current Ratio16.99
Dividend YieldN/A
Payout RatioN/A
Beta2.26

Trading Data

31.75
Open
31.75
Day High
31.75
Day Low
2.01M
Volume (1.0x avg)

Recent News (8)

Earnings Update: Beam Therapeutics Inc. (NASDAQ:BEAM) Just Reported And Analysts Are Boosting Their Estimates
Simply Wall St. · 2026-05-11
BEAM's Q1 Loss Wider Than Expected, Revenues Beat Estimates
Zacks · 2026-05-08
Beam Therapeutics Inc. (BEAM) Reports Q1 Loss, Beats Revenue Estimates
Zacks · 2026-05-07
Why Beam Therapeutics (BEAM) Is Up 5.3% After TIME100 Spotlight and Vanguard Stake Disclosure
Simply Wall St. · 2026-05-04
Beam Therapeutics’ TIME Honor Puts Base Editing And Valuation In Focus
Simply Wall St. · 2026-05-03
Is Beam Therapeutics Inc. (BEAM) A Good Stock To Buy Now?
Insider Monkey · 2026-05-02
Jim Cramer Believes Beam Therapeutics Is a “Speculative Situation”
Insider Monkey · 2026-04-30
Beam Therapeutics (BEAM) Reveals Encouraging Results From Risto-Cel Phase 1/2 BEACON Study
Insider Monkey · 2026-04-29

Price Chart (90 Days)

Candlesticks (green=up, red=down) SMA 20 SMA 50 Bollinger Bands (upper/lower) Volume (green=buying, red=selling)
Powered by Fahodi Methodology. This is analytical output, not financial advice. Always do your own due diligence.  ·  Pipeline status  ·  Data: —